Investigating the implementation and impact of “Better Care Better Value” prescribing policy for Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for treating hypertension in the UK primary care setting
Background: In April 2009, the NHS Institute for Innovation and Improvement released four Better Care Better Value (BCBV) prescribing indicators. One indicator targeted renin–angiotensin–aldosterone system (RAAS) drugs, i.e., angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2016
|
| Online Access: | https://eprints.nottingham.ac.uk/31153/ |